Performance analysis of Alto Neuroscience (ANRO)
Annual Return
Since Feb 2, 2024, ANRO has had an average annual return of +9.65%, underperforming the benchmark SPY, which returned +19.36% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +45.90% | +320.90% | -79.57% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.04% | +27.20% | +14.17% | +14.14% | -21.78% | +31.49% | -1.59% | +45.90% | |||||
| 2025 | +1.42% | -34.70% | -22.91% | +15.34% | +3.57% | -14.69% | +39.51% | +19.89% | +9.22% | +252.99% | -2.39% | +28.52% | +320.90% |
| 2024 | -25.60% | -0.34% | +1.05% | -22.89% | -10.63% | +0.85% | +18.82% | -10.68% | -66.00% | +13.36% | -4.08% | -79.57% |
Drawdown analysis of Alto Neuroscience (ANRO)
The maximum drawdown for the ANRO was -91.74%, occurring on Apr 4, 2025. Recovery took 231 trading sessions.
The current ANRO drawdown is -7.48%.
Since Feb 2, 2024 ANRO has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -91.74% | Feb 5, 2024 | 292 | Apr 4, 2025 | 231 | Mar 9, 2026 | 523 |
| -34.19% | Apr 17, 2026 | 35 | Jun 8, 2026 | 14 | Jun 29, 2026 | 49 |
| -17.74% | Mar 16, 2026 | 10 | Mar 30, 2026 | 9 | Apr 13, 2026 | 19 |
| -11.72% | Jun 29, 2026 | 3 | Jul 2, 2026 | Ongoing | Ongoing | Ongoing |
| -5.05% | Mar 9, 2026 | 1 | Mar 10, 2026 | 1 | Mar 11, 2026 | 2 |
| -3.56% | Mar 11, 2026 | 1 | Mar 12, 2026 | 2 | Mar 16, 2026 | 3 |
| -1.35% | Apr 14, 2026 | 1 | Apr 15, 2026 | 1 | Apr 16, 2026 | 2 |